I've been discussing this topic on Zulip with @The-King-of-Toasters (who's doing the actual work in #21440) over the past few weeks, but it's gotten to the point where some high-level decisions have ...

Ever stared at a new shampoo bottle, brimming with promises, only to feel a pang of dread wondering if it’s just another ...

Confusing messages about Britain's budget this month are undermining the government's credibility, investors, businesses and ...

A recent Bankrate study shows only 21% of Americans say they're planning holiday travel. That's down six percentage points ...

Recommender systems are essential for enhancing user experiences by suggesting items based on individual preferences. However, these systems frequently face the challenge of data imbalance, ...

A growing number of people in Devon, Plymouth and Torbay are turning down vaccinations, and a new report reveals why — with ‘vaccine fatigue’ and fear of side effects among the key reasons. The study, ...

CHARLESTON, S.C. - Many 20- and 30-year-olds say they are feeling twice their age in today’s tech-driven society, and experts say the phenomenon known as “digital aging” is real. Dr. Sarah Coker, ...

2025年10月29日，美国胸腺靶向药物研发商Zag Bio宣布完成A轮融资。本轮融资由AbbVie、Boxer Capital、JDRF T1D Fund、kdT Ventures、Lightspeed Ventures、Mission BioCapital、Pear Ventures、Polaris Partners、Regeneron Ventures和Sanofi ...

Discovery and development of the first systemic therapeutics to deliver self-antigens directly to the thymus to harness the body’s natural mechanism to induce central tolerance Lead program in Type 1 ...

With a new approach to creating thymus-targeted medicines for autoimmune diseases, Zag Bio has emerged from stealth with the help of backing from pharma giants AbbVie, Regeneron and Sanofi. The trio ...